Available therapies for the treatment of obesity. Are lifestyle modifications and pharmacotherapy enough to reduce weight? - review of the literature
DOI:
https://doi.org/10.12775/JEHS.2023.44.01.009Keywords
obesity, obesity treatment, pharmacotherapy in obesity, diet, physical activity obesityAbstract
Introduction: The World Health Organization (WHO) defines obesity as "abnormal or excessive accumulation of adipose tissue that poses a health risk". It results from the interdependencies between genetic, cultural, and socio-economic factors. The choice of therapy in the treatment of overweight and obesity depends on body mass index (BMI), individual predispositions, comorbidities and weight history. Among the treatment methods stand out, dietary modification, lifestyle changes, pharmacotherapy, and bariatric surgery. Each of these treatments can be used individually or as a combination treatment using knowledge of physiology.
The aim of the study is to assess the effectiveness of overweight and obesity treatment using pharmacotherapy and lifestyle modification.
Material and Methods: The research material was collected by searching databases with scientific articles about obesity, pharmacotherapy in obesity, the impact of lifestyle modifications, behavioral behavior, and physical activity on the reduction of body fat. The scientific database Pubmed and Web of Science were used. Research articles, systematic reviews and meta-analyses were included.
Summary Obesity is an epidemic of the 21st century, bringing with it several negative consequences. Prevention of the disease, quick diagnosis, and implementation of appropriate treatment to reduce unnecessary fat and excess weight are extremely important. Lifestyle change including dietary modification, physical activity and pharmacotherapy are promising treatments for overweight and obesity.
References
Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med 2019; 19 (3):205-212.
Pierzak M, Głuszek S. The effect of weight reduction on the sexual function and reproductive health of obese men. Medical Studies 2022; 38 (3): 233–244.
Apovian CM. Obesity: definition comorbidities, causes, and burden. AM J Mang Care 2016; 22(7):176-185.
Green M, Arora K, Prakash S. Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndroment. J. Mol. Sci. 2020; 21(8):2890.
Lin X, Li H. Obesity: Epidemiology, Pathophysiology and Therapetics. Front. Endocrinol. 2021;21:doi:
Wąsowski M, Walicka M, Marcinowska-Suchowierska W. Obesity – definition, epidemiology, pathogenesis. Borgis - Postępy Nauk Medycznych 2013;4: 301-306.
Abenavoli L, Scarpellini E, Colica C , Boccuto L, Salehi B, Sharifi-Rad J , Aiello J , Romano B, De Lorenzo L , Izzo AA, Capasso R. Gut Microbiota and Obesity: A Role for Probiotics. Nutrients 2019; 2690; https://doi.org/10.3390/nu11112690.
Hopkins M, Blundell J. Energy balance, body composition, sedentariness and appetite regulation: pathways to obesity. Clin Sci (Lond);2016 : 1615–1628 https://doi.org/10.1042/CS20160006.
Liu B-N, Liu H-T, Liang Z-H, Wang L-H. Gut microbiota in obesity. World J Gastroenterol. 2021; 27(25): 3837–3850. doi: 10.3748/wjg.v27.i25.3837.
Cuevas-Sierra A, Ramos-Lopez A, Riezu-Boj JI, Milagro FI, Martinez JA. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.Adv Nutr 2019;1:17-30. doi:10.1093/advances/nmy078.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31. doi: 10.1038/nature05414.
Gautier J-F, Choukem S-P, Girard J. Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes. Diabetes Metab 2008;34: 65-72.
doi: 10.1016/S1262-3636(08)73397-4.
Linl X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front. Endocrinol2021;12. https://doi.org/10.3389/fendo.2021.706978.
Safaei M, Sundararajan EA, Driss M, Boulila W, Shapi A. systematic literature review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med. 2021;104754 https://doi.org/10.1016/j.compbiomed.2021.104754
Cheng H, Scott M, Green A, Furnham A. Biomedical, psychological, environmental and behavioural factors associated with adult obesity in a nationally representative sample. J Publ Health 2020; 42 (3): 570-578.
Ishida A, Li Y, Matsuda O, Ishida E. Factors affecting adult overweight and obesity in urban China Pertanika. J Soc Sci Human 2020; 28;503-513.
Sun S, He J, Shen B, Fan X, Chen Y, Yang X. Obesity as a ”self-regulated epidemic”: coverage of obesity in Chinese newspapers Eat. Weight Disord 2020; 26: 569-584.
Al-Raddadi R, Bahijri SM, Jambi HA, Ferns G, Tuomilehto J. The prevalence of obesity and overweight, associated demographic and lifestyle factors, and health status in the adult population of Jeddah, Saudi Arabia Therapeut. Adv Chron Dis 2019; 10: doi: 10.1177/2040622319878997
Xia M, Liu K, Feng J, Zheng Z, Xie X. Prevalence and Risk Factors of Type 2 Diabetes and Prediabetes Among 53,288 Middle-Aged and Elderly Adults in China: A Cross-Sectional Study. Diabetes Metab Syndr Obes 2021; 14:1975-1985. doi: 10.2147/DMSO.S305919.
Lette M, Bemelmans W J E, Breda J, Slobbe L C J, Dias J, Boshuizen L C J. Health care costs attributable to overweight calculated in a standardized way for three European countries. Eur J Health Econ; 2016;17 (1): 61-69.
Brady EM, Bodicoat DH, Hall AP, Yates T, Edwardson C, Davies MJ. Sleep duration, obesity and insulin resistance in a multi-ethnic UK population at high risk of diabetes. Diabetes Res Clin Pract 2018; 139:195-202. doi:10.1016/j.diabres.2018.03.010. Epub 2018 Mar 9.
Wiechert M, Holzapfel Ch. Nutrition Concepts for the Treatment of Obesity in Adults. Nutrients 2022;14:169. https://doi.org/10.3390/ nu14010169.
Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity 2019;3:205-212 DOI: https://doi.org/10.7861/clinmedicine.
Welton S, Minty R, O'Driscoll T, Willms H, Poirier D, Madden S, Kelly L. Intermittent fasting and weight loss. Can Fam Physician. 2020; 66(2): 117–125.
Tsai AG, Wadden TA. The Evolution of Very-Low-Calorie Diets: An Update and Metaanalysis. Obesity 2006;14:1283-1478.
Willoughby D, Hewlings S, Kalman D. Body Composition Changes in Weight Loss: Strategies and Supplementation for Maintaining Lean Body Mass, a Brief Review. Nutrients 2018;10(12):1876. doi: 10.3390/nu10121876
Aragon AA. Schoenfeld BJ, Wildman R, Kleiner S, VanDusseldorp T, Taylor L, Earnest CP, Arciero PJ, Wilborn C, Kalman DS, et al. International society of sports nutrition position stand: Diets and body composition. J Intern Soc Sports Nutr 2017;14:16. doi: 10.1186/s12970-017-0174-y.
Markis A, Foster GD. Dietary Approaches to the Treatment of Obesity. Psychiatr Clin North Am. 2011;34(4): 813–827. doi: 10.1016/j.psc.2011.08.004
Muscogiuria G, El Ghochc M, Colaoa A, Hassapidoud M, Yumuke V, Busettof L. Obesity Management Task Force (OMTF) of the European Association for the Study of Obesity (EASO). Obes Facts 2021;14:222–245. DOI: 10.1159/000515381
Barnard ND, Gloede L, Cohen J, Jenkins DJ, Turner-McGrievy G, Green AA, Ferdowsian H. A low-fat vegan diet elicits greater macronutrient changes, but is comparable in adherence and acceptability, compared with a more conventional diabetes diet among individuals with type 2 diabetes. J Am Diet Assoc. 2009 Feb;109(2):263–72.
Trumbo P, Schlicker S, Yates AA, Poos M. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.
J Am Diet Assoc 2002; 102 :1621-1630. doi: 10.1016/S0002-8223(02)90346-9.
Dong TS, Luu K, Lagishetty V, Sedighian F et all. A High Protein Calorie Restriction Diet Alters the Gut Microbiome in Obesity. Nutrients 2020;12:3221. doi:10.3390/nu12103221
Davis JJ, Fournakis N, Ellison J. Ketogenic Diet for the Treatment and Prevention of Dementia: A Review. Journal of Geriatric Psychiatry and Neurology 2021; 34: 3-10. https://doi.org/10.1177/0891988720901785
Paoli A. Ketogenic Diet for Obesity: Friend or Foe? Int J Environ Res Public Health. 2014 Feb; 11(2): 2092–2107. doi: 10.3390/ijerph110202092
Brouns F. Overweight and diabetes prevention: is a low-carbohydrate-high-fat diet recommendable? Eur J Nutr 2018;57 (4):1301-1312. Doi:10.1007/s00394-018-1636-y.
Tak J, Lee S. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? Current Obesity Reports 2021;10:14-30. DOI: 10.1007/s13679-020-00422-w
Gadde KM, Martin CK, Berthoud H-D. Obesity: Pathophysiology and Management. Journal of American College of Cardiology 2018;71:69-84.
Aaseth J, Ellefsen S, Alehagen U et all. Diets and drugs for weight loss and health in obesity-An update. Biomed Pharmacother 2021 Aug;140:111789.doi: 10.1016/j.biopha.2021.111789. Epub 2021
GjermeniE,Kirstein AS, Kolbig F, Kirchhof F, Bundalian L, Katzmann JL, Laufs U, Matthias Blüher M, Garten A, Le Duc D. Obesity-An Update on the Basic Pathophysiology and Review of Recent Therapeutic Advances. Biomolecules 2021 Sep 29;11(10):1426.doi: 10.3390/biom11101426.
Bersoux S, Byun TH, Chaliki SS, Poole KG. Pharmacotherapy for obesity: What you need to know. Cleve Clin J Med 2017; 84(12):951-958. doi: 10.3949/ccjm.84a.16094.
Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med 2000; 9:160–167.
Allison DB, Kishore M. Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, Tam PY, Troupin B, Da WW. Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP). Obesity 2012;20(2);330-342. https://doi.org/10.1038/oby.2011.330
Singh AK, Singh R. Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized. controlled trials of anti-obesity drugs. Expert Rev Clin Pharmacol 2020;13:53-64.
May M, Schindler CH, Engeli S. Modern pharmacological treatment of obese patients. Ther Adv Endocrinol Metab 2020;11:doi10.1177/2042018819897527.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Monika Pierzak-Stępień
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 1551
Number of citations: 0
